Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Deucravacitinib helped a man regrow hair significantly.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

RTA 408 cream protects mice from radiation skin damage.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

A new treatment using a special gel with miR-665 reduces inflammation and helps hair regrow in alopecia areata.

Upadacitinib improved multiple immune-related conditions in one patient.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

4-(Ethoxycarbophenyl) retinamide is much less toxic than other retinoids.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Dermatological treatments can have significant side effects, including allergic reactions, sexual dysfunction, and increased cancer risk.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

A man's hair loss was linked to his HIV medication, which improved after changing drugs.

ATP helps prevent skin damage from vandetanib by reducing stress.

A woman got male pattern baldness from touching her husband's testosterone gel.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

A botanical extract was found to be a safe treatment that may prevent hair loss in chemotherapy patients.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.